KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Return on Sales (2016 - 2025)

Historic Return on Sales for Travere Therapeutics (TVTX) over the last 13 years, with Q3 2025 value amounting to 0.0%.

  • Travere Therapeutics' Return on Sales changed 0.0% to 0.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.0% for FY2024, which is 18300.0% down from last year.
  • Travere Therapeutics' Return on Sales amounted to 0.0% in Q3 2025, which was down 0.0% from 0.0% recorded in Q2 2025.
  • Travere Therapeutics' Return on Sales' 5-year high stood at 6.47% during Q3 2023, with a 5-year trough of 1.14% in Q1 2021.
  • For the 5-year period, Travere Therapeutics' Return on Sales averaged around 0.38%, with its median value being 0.0% (2025).
  • Per our database at Business Quant, Travere Therapeutics' Return on Sales skyrocketed by 59600bps in 2023 and then plummeted by -64700bps in 2024.
  • Quarter analysis of 5 years shows Travere Therapeutics' Return on Sales stood at 0.56% in 2021, then increased by 20bps to 0.68% in 2022, then plummeted by -105bps to 0.03% in 2023, then skyrocketed by 100bps to 0.0% in 2024, then crashed by -83bps to 0.0% in 2025.
  • Its Return on Sales stands at 0.0% for Q3 2025, versus 0.0% for Q2 2025 and 0.0% for Q1 2025.